HCHui Chen

Hui Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hui Chen has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Chang Xiao

    Department of Pathogen Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China

    1 shared publication
  • Cheng Jin

    Department of Medical Microbiology & Parasitology, MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University Shanghai Medical College, Shanghai, China

    1 shared publication
  • Cheng Wu

    Department of Pathogen Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China

    1 shared publication
  • Dun Pan

    Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute for Basic Medical Sciences, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China

    1 shared publication
  • Guo Li

    Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute for Basic Medical Sciences, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China

    1 shared publication
  • Hong Lin

    Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute for Basic Medical Sciences, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Gut Microbiota Restructuring and Elizabethkingia Enrichment in Aedes albopictus Larvae Under Pyriproxyfen Exposure

    by Li-Hua Xie, Sheng-Yu Xu, Yue Wang, Xin-Bei Wu, Chang Xiao, Xiu-Li Zhang, Cheng Wu, Hui Chen

    Aedes albopictus transmits dengue, chikungunya, and Zika viruses, and its expanding range, together with widespread insecticide resistance, threatens the sustainability of chemical vector control. Pyriproxyfen (PPF) is an insect growth regulator used in mosquito control, but the relationship between gut bacteria and larval responses to PPF remains poorly characterized. We combined 16S rRNA gene amplicon sequencing with culture-dependent isolation to characterize gut bacterial communities in Ae. albopictus following acute PPF exposure and identify candidates for functional investigation. The 24 h median lethal concentration (LC50) for the Fuzhou population was 10.27 mg/L. Community profiles were compared among Fuzhou larvae dying at 2× LC50, surviving at 5× LC50, and receiving solvent alone; solvent-treated Foshan laboratory larvae served as an external population reference. Bacterial richness and Shannon diversity were lower in both exposed Fuzhou groups than in the Fuzhou solvent-treated control, and community structure differed among the four groups (PERMANOVA, R2 = 0.797, p = 0.001). Elizabethkingia accounted for 35.0% of bacterial reads in survivors, compared with 22.8% in non-survivors and 7.6% in Fuzhou solvent-treated controls, with significantly higher relative abundance in survivors than in either comparison group. Culture-dependent isolation from survivors yielded 29 isolates representing nine genera, including three isolates assigned to Elizabethkingia anophelis by 16S rRNA gene sequencing. Concordant sequencing and culture-based evidence, together with the recovery of viable isolates, positions Elizabethkingia as a tractable entry point into this question, opening a route to ask whether the larval microbiota can be managed to preserve the efficacy of pyriproxyfen-based control as resistance to other insecticide classes spreads.

  • BRD4 regulates PAI-1 expression in tumor-associated macrophages to drive chemoresistance in colorectal cancer

    by Dun Pan, Jinfeng Hu, Guo Li, Xuming Gao, Jie Wang, Leisi Jiang, Hong Lin, Yulin Chen, Yanheng Chen, Yiran Zheng, et al.

    Tumor-associated macrophages (TAMs) in the tumor microenvironment play a key role in drug resistance, but the mechanisms underlying TAM polarization and its role in drug resistance remain unclear. Here, we identified BRD4 as a critical factor in TAM polarization and drug resistance in colorectal cancer (CRC). BRD4 deficiency in macrophages impaired M2-like TAM polarization, and tumors from myeloid-lineage specific Brd4 conditional knockout (Brd4-CKO) mice displayed a reduction in infiltrating M2-like TAMs and an enhanced anti-tumor microenvironment. Colon cancer cells treated with conditioned medium from polarized Brd4-deficient TAMs, as well as tumors in Brd4-CKO mice, were more sensitive to oxaliplatin. RNA-seq and cytokine microarray analysis revealed that mRNA and protein levels of PAI-1 were significantly decreased in Brd4-deficient polarized TAMs. BRD4 was recruited to the promoter of Serpine1, promoting SMAD-dependent PAI-1 expression. Supplementing Brd4-deficient TAMs with recombinant PAI-1 hampered the sensitivity of colon cancer cells to oxaliplatin. Moreover, PAI-1 inhibitor and oxaliplatin synergistically suppressed the growth of colon tumors. Clinically, the expression levels of BRD4 in TAMs and PAI-1 in tumors were elevated in CRC patients with chemoresistance, correlating with shorter recurrence-free survival. Collectively, our findings uncover a novel role for BRD4 in TAM polarization and drug resistance via PAI-1 upregulation, suggesting the BRD4/PAI-1 axis as a potential prognostic marker and therapeutic target in CRC.


  • Recent developments and new directions in the use of natural products for the treatment of inflammatory bowel disease

    by Yaqian Feng, Mengting Pan, Ruiqiong Li, Weishen He, Yangyang Chen, Shaohua Xu, Hui Chen, Huilong Xu, Yao Lin


  • GPCRs involved in metabolic diseases: pharmacotherapeutic development updates

    by Cheng Jin, Hui Chen, Li Xie, Yuan Zhou, Li-Li Liu, Jian Wu

    G protein-coupled receptors (GPCRs) are expressed in a variety of cell types and tissues, and activation of GPCRs is involved in enormous metabolic pathways, including nutrient synthesis, transportation, storage or insulin sensitivity, etc. This review intends to summarize the regulation of metabolic homeostasis and mechanisms by a series of GPCRs, such as GPR91, GPR55, GPR119, GPR109a, GPR142, GPR40, GPR41, GPR43 and GPR120. With deep understanding of GPCR’s structure and signaling pathways, it is attempting to uncover the role of GPCRs in major metabolic diseases, including metabolic syndrome, diabetes, dyslipidemia and nonalcoholic steatohepatitis, for which the global prevalence has risen during last two decades. An extensive list of agonists and antagonists with their chemical structures in a nature of small molecular compounds for above-mentioned GPCRs is provided as pharmacologic candidates, and their preliminary data of preclinical studies are discussed. Moreover, their beneficial effects in correcting abnormalities of metabolic syndrome, diabetes and dyslipidemia are summarized when clinical trials have been undertaken. Thus, accumulating data suggest that these agonists or antagonists might become as new pharmacotherapeutic candidates for the treatment of metabolic diseases.